Navigation Links
Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data

  • Nine out of 10 non-diabetic patients treated with Exforge achieved recommended blood pressure goals[1]
  • Additional average decrease of 20 mmHg in systolic blood pressure observed in patients taking Exforge over reductions seen with previous monotherapy[1]
  • Nearly 70% of those with high blood pressure not at treatment target levels[2] and most require two or more medications to achieve goal[2]
BASEL, Switzerland, May 21, 2007 - Exforge®, a single-tablet combination of two of the world's most commonly prescribed high blood pressure medicines[3],[4], has been shown in new clinical data to have helped nine out of 10 non-diabetic patients to reach their treatment goals after having previously failed to do so with single medicines[1].
The results showed patients taking Exforge experienced on average an additional 20 mmHg drop in systolic blood pressure compared to reductions seen with their previous medication[1]. The data from this trial involving 894 patients were presented today at the Annual Scientific Meeting of the American Society of Hypertension (ASH) in Chicago.
The efficacy of Exforge, which combines the angiotensin receptor blocker (ARB) valsartan (Diovan®) and the calcium channel blocker (CCB) amlodipine in one tablet, was again demonstrated in this trial, even in patients considered to be more difficult to treat such as the elderly or those with type 2 diabetes[1]. Exforge was well-tolerated at the doses used in this trial[1].
The study - designed to assess the use of Exforge in a real-life treatment environment - showed that patients who had failed to reach the recommended blood pressure goal of 140/90 mmHg (systolic/diastolic pressure) on a range of si
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. ApoCells Cancer Predictive Index Helps Oncologists Select the Most Effective Targeted Drug Therapy
2. Study Suggests Invega Helps Patients With Schizophrenia Maintain Symptom Control
3. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
4. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
5. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
6. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
7. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
8. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
9. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
10. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
11. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
Post Your Comments:
(Date:8/22/2014)... ITHACA, N.Y. , Aug. 22, 2014 /PRNewswire/ ... computed tomography (CT) imaging facility, is using the ... 4D and even 5D imaging to researchers and ... just launched, asks "What would YOU do if ... the possibility to researchers and explorers everywhere, from ...
(Date:8/22/2014)... 22, 2014 /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: ... commercializes proprietary technologies and products for advanced microarray ... a Master Service Agreement to contract with a ... assays. During the initial phase of this agreement, ... working prototype of one of the customer,s assays, ...
(Date:8/21/2014)... AUSTIN, Texas , Aug. 21, 2014  Vermillion, ... company focused on gynecologic cancers and women,s health, has ... of Sales and Managed Markets. Ms. Bauzon ... traction and expanding payer coverage for laboratory services companies. ... most recently with PerkinElmer, Inc., where she held the ...
Breaking Medicine Technology:Cornell's X-ray Imaging Lab Director Uses Kickstarter Campaign to "Democratize" Advanced 3D Imaging 2SQI Diagnostics Contracted to Automate Pathogen Detection Assays 2SQI Diagnostics Contracted to Automate Pathogen Detection Assays 3Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets 2
(Date:8/22/2014)... treated for the cancer Hodgkin lymphoma will be able ... researchers estimated their risk of premature menopause with different ... Journal of the National Cancer Institute , are based ... in England and Wales treated for the cancer over ... research has suggested that women with Hodgkin lymphoma who ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Human induced ... field of regenerative medicine because they can be coaxed ... don’t always act as anticipated. They sometimes mutate, develop ... in a new study recently published in STEM CELLS ... around this, simply by removing the material used to ...
(Date:8/22/2014)... Thompson HealthDay Reporter ... American health-care workers infected with the deadly Ebola virus ... been released from the Atlanta hospital where they have ... Dr. Kent Brantly, 33, was released from Emory ... hospital Tuesday. Her family said the 59-year-old woman is ...
(Date:8/22/2014)... 22, 2014 Goats are taking over Beverly ... attends the 10th annual Pre-Emmy Awards Boom Boom Room. Celebrities ... the best new products for kids on August 23 at ... and we’ll be encouraging them to #GoGoat for L.A. families ... to present our gentle, non-GMO goat milk foods to health-conscious ...
(Date:8/22/2014)... 2014 Being optimistic about the ... some foreign and domestic companies are speeding up ... and acquisitions. In 2012, Medtronic, Inc. acquired the ... Kanghui Holdings for USD 816 million; In Jan. ... makers-- Trauson Holdings Company Limited for HKD5.9 billion; ...
Breaking Medicine News(10 mins):Health News:Scientists map risk of premature menopause after cancer treatment 2Health News:Removing Programming Material After Inducing Stem Cells Could Improve Their Regeneration Ability 2Health News:Both U.S. Health-Care Workers Infected With Ebola Released From Hospital 2Health News:Both U.S. Health-Care Workers Infected With Ebola Released From Hospital 3Health News:#GoGoat with Kabrita at the Pre-Emmy Awards Boom Boom Room 2Health News:China Orthopedic Instrument Industry 2014- Global Industry Size, Share, Trend, Growth and Forecast 2017 2
... Host Free Webcast on Making a Smooth Transition to the ... Incorporated (NYSE: IRM ), the global leader in ... share tips during an upcoming Webcast for how healthcare providers ... , In this free, hour-long Webcast, attendees will learn the ...
... researcher says , THURSDAY, June 4 (HealthDay News) -- ... the world don,t perform as well as males in math. ... the United States and abroad that appears in the June 1 ... , "There are countries where the gender disparity in math ...
... June 4 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: ... and services to the global life sciences markets, today ... financial results on Thursday, June 11, 2009. , The ... analysts with Stephen P. DeFalco, President and Chief Executive ...
... , , Proven Interoperability Solution Expands ... Carestream, Intergy RIS, Cloverleaf, Meditech RIS, McKesson, PowerScribe ... June 4 Healthcare IT workflow management pioneer ... its comprehensive suite of Enterprise digital imaging and ...
... plans reduce audit risk while ensuring accurate payments and compliance with ... a select few have ever wondered how to integrate Medicare Risk ... hear about the latest release from Storan Technologies Inc. ... of Merlin Medicare Risk Adjustment 6.0 (TM), a ...
... relief for pain, strengthening of immune systems and more , ... more research is showing that most illness, disease and other ... of the cellular immune system with essential nutrition. Key to ... nutrients and water. This is something that,s become more difficult ...
Cached Medicine News:Health News:Best Practices for Hospitals Moving to Electronic Medical Records 2Health News:Girls and Math: Blame the Culture, Not Ability 2Health News:Compressus Delivers Imaging Productivity & Efficiency Improvements in Next Generation MEDxConnect(TM) Workflow Management Solution 2Health News:Compressus Delivers Imaging Productivity & Efficiency Improvements in Next Generation MEDxConnect(TM) Workflow Management Solution 3Health News:Compressus Delivers Imaging Productivity & Efficiency Improvements in Next Generation MEDxConnect(TM) Workflow Management Solution 4Health News:St. Louis Firm Brings Medicare Risk Adjustment to iPhone 2Health News:Breakthrough Nanotechnology Delivers Safe, Nutrition-Packed Cellular Hydration 2Health News:Breakthrough Nanotechnology Delivers Safe, Nutrition-Packed Cellular Hydration 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: